Suppression of human immunodeficiency virus type 1 replication in macrophages by commensal bacteria preferentially stimulating Toll-like receptor 4

Journal of General Virology

Volumn 91, Issue 11, 2010, Pages 2804-2813

  Ahmed, Nursarat ^a   Hayashi, Takaya ^a   Hasegawa, Atsuhiko ^a   Furukawa, Hiroyuki ^a   Okamura, Noboru ^a   Chida, Toshio ^a   Masuda, Takao ^a   Kannagi, Mari ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; BETA INTERFERON RECEPTOR; INTERFERON; NEUTRALIZING ANTIBODY; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; LUCIFERASE; TLR2 PROTEIN, HUMAN; TLR3 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 2;

ARTICLE; CELL LINE; COMMENSAL; CONTROLLED STUDY; ESCHERICHIA COLI; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; INNATE IMMUNITY; LACTOBACILLUS ACIDOPHILUS; MACROPHAGE; MONOCYTE; MYCOBACTERIUM SMEGMATIS; NEISSERIA MUCOSA; NONHUMAN; PREVOTELLA BIVIA; PREVOTELLA MELANINOGENICA; PRIORITY JOURNAL; VEILLONELLA PARVULA; VIRUS REPLICATION; VIRUS RESISTANCE; BACTERIA; CELL SURVIVAL; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; REPORTER GENE; VIROLOGY;

BACTERIA; CELL LINE; CELL SURVIVAL; GENES, REPORTER; HIV-1; HUMANS; INTERFERON TYPE I; LUCIFERASES; MACROPHAGES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; VIRUS REPLICATION;

ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS 1; LACTOBACILLUS ACIDOPHILUS; MYCOBACTERIUM SMEGMATIS; NEISSERIA MUCOSA; PREVOTELLA MELANINOGENICA; VEILLONELLA PARVULA;

EID: 78049363385     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.022442-0     Document Type: Article

References (44)

1. Auwerx, J. (1991). The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 47, 22-31.
2. Barouch, D. H. (2008). Challenges in the development of an HIV-1 vaccine. Nature 455, 613-619.
3. Beignon, A. S., McKenna, K., Skoberne, M., Manches, O., DaSilva, I., Kavanagh, D. G., Larsson, M., Gorelick, R. J., Lifson, J. D. & Bhardwaj, N. (2005). Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 115, 3265-3275. (Pubitemid 41567591)
4. Biasin, M., Piacentini, L., Lo Caputo, S., Naddeo, V., Pierotti, P., Borelli, M., Trabattoni, D., Mazzotta, F., Shearer, G. M. & Clerici, M. (2010). TLR activation pathways in HIV-1-exposed seronegative individuals. J Immunol 184, 2710-2717.
5. Bouskra, D., Brezillon, C., Berard, M., Werts, C., Varona, R., Boneca, I. G. & Eberl, G. (2008). Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456, 507-510. (Pubitemid 352759006)
6. + T cells. Science 270, 1811-1815.
7. Doyle, S., Vaidya, S., O'Connell, R., Dadgostar, H., Dempsey, P., Wu, T., Rao, G., Sun, R., Haberland, M. & other authors (2002). IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17, 251-263. (Pubitemid 35279547)
8. Equils, O., Schito, M. L., Karahashi, H., Madak, Z., Yarali, A., Michelsen, K. S., Sher, A. & Arditi, M. (2003). Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat transactivation and HIV replication in HIV-1 transgenic mouse spleen cells: implications of simultaneous activation of TLRs on HIV replication. J Immunol 170, 5159-5164. (Pubitemid 36554748)
9. Equils, O., Salehi, K. K., Cornataeanu, R., Lu, D., Singh, S., Whittaker, K. & Baldwin, G. C. (2006). Repeated lipopolysaccharide (LPS) exposure inhibits HIV replication in primary human macrophages. Microbes Infect 8, 2469-2476. (Pubitemid 44515147)
10. Fowke, K. R., Nagelkerke, N. J., Kimani, J., Simonsen, J. N., Anzala, A. O., Bwayo, J. J., MacDonald, K. S., Ngugi, E. N. & Plummer, F. A. (1996). Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 348, 1347-1351. (Pubitemid 26383775)
11. Gurney, K. B., Colantonio, A. D., Blom, B., Spits, H. & Uittenbogaart, C. H. (2004). Endogenous IFN-α production by plasmacytoid dendritic cells exerts an antiviral effect on thymic HIV-1 infection. J Immunol 173, 7269-7276. (Pubitemid 39628163)
12. Heggelund, L., Muller, F., Lien, E., Yndestad, A., Ueland, T., Kristiansen, K. I., Espevik, T., Aukrust, P. & Froland, S. S. (2004). Increased expression of Toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication. Clin Infect Dis 39, 264-269. (Pubitemid 38971499)
13. Herbeuval, J. P. & Shearer, G. M. (2007). HIV-1 immunopathogenesis: how good interferon turns bad. Clin Immunol 123, 121-128.
14. Hijiya, N., Miyake, K., Akashi, S., Matsuura, K., Higuchi, Y. & Yamamoto, S. (2002). Possible involvement of Toll-like receptor 4 in endothelial cell activation of larger vessels in response to lipopolysaccharide. Pathobiology 70, 18-25. (Pubitemid 36151549)
15. Hirai, H., Suzuki, T., Fujisawa, J., Inoue, J. & Yoshida, M. (1994). Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor κB and induces nuclear translocation of transcription factor NF-κB proteins for transcriptional activation. Proc Natl Acad Sci U S A 91, 3584-3588. (Pubitemid 24984874)
16. Hosmalin, A. & Lebon, P. (2006). Type I interferon production in HIV-infected patients. J Leukoc Biol 80, 984-993. (Pubitemid 44646304)
17. Ikeda, T., Nishitsuji, H., Zhou, X., Nara, N., Ohashi, T., Kannagi, M. & Masuda, T. (2004). Evaluation of the functional involvement of human immunodeficiency virus type 1 integrase in nuclear import of viral cDNA during acute infection. J Virol 78, 11563-11573. (Pubitemid 39390742)
18. Johnson-Henry, K. C., Donato, K. A., Shen-Tu, G., Gordanpour, M. & Sherman, P. M. (2008). Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157 : H7-induced changes in epithelial barrier function. Infect Immun 76, 1340-1348. (Pubitemid 351561979)
19. Kaul, R., Trabattoni, D., Bwayo, J. J., Arienti, D., Zagliani, A., Mwangi, F. M., Kariuki, C., Ngugi, E. N., MacDonald, K. S. & other authors (1999). HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 13, 23-29. (Pubitemid 29078060)
20. + lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol 164, 1602-1611.
21. + responses. J Clin Invest 107, 341-349.
22. Klebanoff, S. J. & Coombs, R. W. (1991). Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J Exp Med 174, 289-292.
23. Koyanagi, Y., Miles, S., Mitsuyasu, R. T., Merrill, J. E., Vinters, H. V. & Chen, I. S. (1987). Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236, 819-822. (Pubitemid 17071156)
24. Liu, X., Mosoian, A., Li-Yun Chang, T., Zerhouni-Layachi, B., Snyder, A., Jarvis, G. A. & Klotman, M. E. (2006). Gonococcal lipooligosaccharide suppresses HIV infection in human primary macrophages through induction of innate immunity. J Infect Dis 194, 751-759.
25. Mares, D., Simoes, J. A., Novak, R. M. & Spear, G. T. (2008). TLR2-mediated cell stimulation in bacterial vaginosis. J Reprod Immunol 77, 91-99.
26. Matera, G., Muto, V., Vinci, M., Zicca, E., Abdollahi-Roodsaz, S., van de Veerdonk, F. L., Kullberg, B. J., Liberto, M. C., van der Meer, J. W. & other authors (2009). Receptor recognition of and immune intracellular pathways for Veillonella parvula lipopolysaccharide. Clin Vaccine Immunol 16, 1804-1809.
27. Meier, A., Alter, G., Frahm, N., Sidhu, H., Li, B., Bagchi, A., Teigen, N., Streeck, H., Stellbrink, H. J. & other authors (2007). MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J Virol 81, 8180-8191.
28. Meltzer, M. S., Nakamura, M., Hansen, B. D., Turpin, J. A., Kalter, D. C. & Gendelman, H. E. (1990). Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease. AIDS Res Hum Retroviruses 6, 967-971.
29. NCCLS (1992). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard M27-A2, 2nd edn. Wayne, PA: Clinical and Laboratory Standards Institute. http://www.clsi.org/source/orders/ free/M27-A3.pdf
30. Ogawa, Y., Kawamura, T., Kimura, T., Ito, M., Blauvelt, A. & Shimada, S. (2009). Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation. Blood 113, 5157-5166.
31. Planelles, V., Haislip, A., Withers-Ward, E. S., Stewart, S. A., Xie, Y., Shah, N. P. & Chen, I. S. (1995). A new reporter system for detection of retroviral infection. Gene Ther 2, 369-376.
32. Plummer, F. A., Ball, T. B., Kimani, J. & Fowke, K. R. (1999). Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop? Immunol Lett 66, 27-34.
33. Ravanfar, P., Mendoza, N., Satyaprakash, A. & Jordan, B. I. (2009). HIV vaccines under study. Dermatol Ther 22, 158-167.
34. Resta-Lenert, S. & Barrett, K. E. (2006). Probiotics and commensals reverse TNF-α- and IFN-γ-induced dysfunction in human intestinal epithelial cells. Gastroenterology 130, 731-746.
35. Romano Carratelli, C., Mazzola, N., Paolillo, R., Sorrentino, S. & Rizzo, A. (2009). Toll-like receptor-4 (TLR4) mediates human β-defensin-2 (HBD-2) induction in response to Chlamydia pneumoniae in mononuclear cells. FEMS Immunol Med Microbiol 57, 116-124.
36. Sekaly, R. P. (2008). The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? J Exp Med 205, 7-12.
37. Shattock, R. J., Friedland, J. S. & Griffin, G. E. (1993). Release of human immunodeficiency virus by THP-1 cells and human macrophages is regulated by cellular adherence and activation. J Virol 67, 3569-3575.
38. Simard, S., Maurais, E., Gilbert, C. & Tremblay, M. J. (2008). LPS reduces HIV-1 replication in primary human macrophages partly through an endogenous production of type I interferons. Clin Immunol 127, 198-205.
39. Spear, G. T., St John, E. & Zariffard, M. R. (2007). Bacterial vaginosis and human immunodeficiency virus infection. AIDS Res Ther 4, 25.
40. Takeda, K. & Akira, S. (2004). TLR signaling pathways. Semin Immunol 16, 3-9.
41. Trapp, S., Derby, N. R., Singer, R., Shaw, A., Williams, V. G., Turville, S. G., Bess, J. W., Jr, Lifson, J. D. & Robbiani, M. (2009). Double-stranded RNA analog poly(I : C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G. J Virol 83, 884-895.
42. Troy, E. B. & Kasper, D. L. (2010). Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. Front Biosci 15, 25-34.
43. Verani, A., Scarlatti, G., Comar, M., Tresoldi, E., Polo, S., Giacca, M., Lusso, P., Siccardi, A. G. & Vercelli, D. (1997). C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J Exp Med 185, 805-816.
44. Zarember, K. A. & Godowski, P. J. (2002). Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168, 554-561.